Alpha-thalassemia
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Alpha-thalassemia | |
|---|---|
| File:Thalassemia alpha.jpg | |
| Synonyms | α-thalassemia |
| Pronounce | |
| Specialty | Hematology |
| Symptoms | Anemia, fatigue, pallor, jaundice, splenomegaly |
| Complications | Hydrops fetalis, iron overload |
| Onset | Birth |
| Duration | Lifelong |
| Types | Alpha-thalassemia trait, Hemoglobin H disease, Hemoglobin Bart's hydrops fetalis |
| Causes | Genetic mutations in the HBA1 and HBA2 genes |
| Risks | Family history, Southeast Asian, Mediterranean, Middle Eastern, African descent |
| Diagnosis | Complete blood count, hemoglobin electrophoresis, genetic testing |
| Differential diagnosis | Beta-thalassemia, iron deficiency anemia, sideroblastic anemia |
| Prevention | Genetic counseling |
| Treatment | Blood transfusion, iron chelation therapy, bone marrow transplant |
| Medication | Deferoxamine, Deferasirox |
| Prognosis | Variable, depending on type |
| Frequency | Common in certain populations |
| Deaths | N/A |
Alpha-thalassemia is a blood disorder that reduces the production of hemoglobin. Hemoglobin is the protein in red blood cells that carries oxygen to cells throughout the body. Alpha-thalassemia is caused by mutations in the HBA1 and HBA2 genes, which are responsible for the production of alpha-globin, a component of hemoglobin.
Pathophysiology[edit]
In alpha-thalassemia, the production of alpha-globin chains is reduced or absent. This leads to an imbalance in the ratio of alpha to beta-globin chains, resulting in the formation of abnormal hemoglobin molecules. The severity of the disease depends on the number of affected alpha-globin genes.
Genetic Basis[edit]
The HBA1 and HBA2 genes are located on chromosome 16. Each person has four alpha-globin genes, two from each parent. The severity of alpha-thalassemia is determined by the number of gene deletions:
- Silent Carrier: One gene deletion, usually asymptomatic.
- Alpha-thalassemia Trait: Two gene deletions, mild anemia.
- Hemoglobin H Disease: Three gene deletions, moderate to severe anemia.
- Hydrops Fetalis: Four gene deletions, usually fatal before or shortly after birth.
Clinical Features[edit]
The clinical presentation of alpha-thalassemia varies depending on the number of affected genes.
Silent Carrier[edit]
Individuals with one deleted alpha-globin gene are typically asymptomatic and have normal hematological parameters.
Alpha-thalassemia Trait[edit]
Individuals with two deleted alpha-globin genes may have mild anemia and microcytosis. They are often asymptomatic and may be identified during routine blood tests.
Hemoglobin H Disease[edit]
This condition results from the deletion of three alpha-globin genes. It is characterized by:
- Moderate to severe anemia
- Splenomegaly
- Jaundice
- Bone deformities
Hydrops Fetalis[edit]
This is the most severe form of alpha-thalassemia, resulting from the deletion of all four alpha-globin genes. It leads to:
- Severe anemia
- Heart failure
- Edema
- Usually results in stillbirth or death shortly after birth
Diagnosis[edit]
Diagnosis of alpha-thalassemia involves:
- Complete blood count (CBC) showing microcytic anemia
- Hemoglobin electrophoresis
- Genetic testing to identify deletions in the HBA1 and HBA2 genes
Management[edit]
Management of alpha-thalassemia depends on the severity of the disease:
- Silent Carrier and Alpha-thalassemia Trait: Usually require no treatment.
- Hemoglobin H Disease: May require regular blood transfusions, folic acid supplementation, and splenectomy in severe cases.
- Hydrops Fetalis: Prenatal diagnosis and counseling are important. Intrauterine transfusions may be considered.
Prognosis[edit]
The prognosis of alpha-thalassemia varies:
- Silent carriers and individuals with alpha-thalassemia trait generally have a normal life expectancy.
- Hemoglobin H disease can lead to complications but is manageable with treatment.
- Hydrops fetalis is usually fatal without intervention.
Prevention[edit]
Genetic counseling is recommended for at-risk couples. Prenatal testing can identify affected fetuses, allowing for informed decision-making.
